pSivida announced that the company has launched a new corporate communication system, with portals on social media channels such as Facebook, Twitter, and LinkedIn. The system has been designed to allow for the company to pass on important information to shareholders and others. This is accompanied by a site dedicated to allowing executives to publish blog entries.
Based in Watertown, MA, pharmaceutical company pSivida is focused on the production of sustained release drug delivery products, such as ILUVIEN, intended for the treatment of chronic Diabetic Macula Edema. These products are designed to deliver drugs at a controlled and steady rate for months or years, and have received marketing authorization in Austria, France, Germany, Portugal, the U.K., and Spain and is awaiting authorization in Italy.
pSivida’s announcement arrives shortly after the SEC’s decision to allow companies the ability to publish material, nonpublic information via social media outlets, such as Facebook and Twitter. The company states that it will routinely post information that may be important to investors in the Investor Relations section of its Web site.
“pSivida has always believed it is important to provide communication with shareholders and others,” said Ashton. “These new online channels will provide us another method to reach them.”
For more information, visit www.psivida.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
